Goldman Sachs
IQMDU

Goldman Sachs’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Goldman Sachs’s Portfolio IQMDU Stock Details IQMDU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-202,135
Closed -$2.06M – 7064
2021
Q4 		$2.06M Buy
+202,135
New +$2.05M ﹤0.01% 4223

Other funds holding IQMDU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Goldman Sachs's IQMDU Position: Q1 2022 in Review

Goldman Sachs sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q1 2022, closing a stake of 202,135 shares — an estimated $2.06M sold.

Goldman Sachs first reported a position in IQMDU in Q4 2021 and held it in 1 quarter. The position peaked at $2.06M in Q4 2021. 26 funds tracked by Wall St. Rank hold IQMDU as of Q1 2022.

  • Goldman Sachs reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q1 2022 after selling out during the quarter.
  • Goldman Sachs sold 202,135 Intelligent Medicine Acquisition Corp. Unit shares in Q1 2022, an estimated $2.06M.
  • Goldman Sachs first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 1 quarter.
  • Goldman Sachs's Intelligent Medicine Acquisition Corp. Unit position peaked at $2.06M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q1 2022.

Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.